

Ranisan - coated tablets:
1 tab. contains Ranitidine (as hydrochloride) 75 and 150 mg; in the package of blister strip 10 pcs.; in a carton pack of 1 (75 mg) or 2 (150 mg) packs.
Anti-ulcer. Ranisan reduces acid production, blocks histamine H2 receptors.
Peptic ulcer of the stomach and duodenum, reflux esophagitis, Zollinger-Ellison syndrome, diseases accompanied by increased acidity of gastric juice.
Hypersensitivity, ulcer malignancy.
Not recommended.
Headache, dizziness, depression, diarrhea, rash, allergic reactions, transient increase in serum hepatic transaminases. Very rare: reversible leukopenia and thrombocytopenia, bradycardia, hypotension, angioedema, erythema of the skin.
Ranisan is taken orally, regardless of the meal, without chewing, with a small amount of liquid.
The initial dose - 150 mg per day, if necessary, the dose may be increased.
At temperatures not above 25 ° C. Shelf life - 3 years.